At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,000 enrolled
Drug / intervention
Descemet Membrane Endothelial Keratoplasty (DMEK)procedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective Clinical Study on Descemet Membrane Endothelial Keratoplasty (DMEK)
Netherlands Institute for Innovative Ocular Surgery·interventional·Posted Aug 28, 2007·Updated Jan 12, 2023
In Brief
A clinical study evaluating Descemet Membrane Endothelial Keratoplasty (DMEK) for Corneal Dystrophies, Hereditary. Completed, enrolled 1,000 participants across 1 site.
Detailed Summary
To evaluate isolated Descemet membrane transplantation as a refinement of previous advanced techniques for corneal transplantation, like Descemet Stripping Endothelial Keratoplasty (DSEK)
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCorneal Dystrophies, Hereditary
CountriesNetherlands
CollaboratorsAmnitrans Eyebank Rotterdam
Timeline
N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2005
First PostedAug 2007
Primary CompletionFeb 2020
TodayJul 2026
First PostedAug 28, 2007
Enrollment StartFeb 1, 2005
Primary CompletionFeb 1, 2020
TodayJul 2, 2026
Enrollment to primary: 15 yearsPosted 18.8 years ago
Interventions
Descemet Membrane Endothelial Keratoplasty (DMEK)procedure